Dongwha Pharm.Co.,Ltd (000020.KS)

KRW 6360.0

(-1.7%)

Long Term Debt Summary of Dongwha Pharm.Co.,Ltd

  • Dongwha Pharm.Co.,Ltd's latest annual long term debt in 2023 was 16.12 Billion KRW , up 688.9% from previous year.
  • Dongwha Pharm.Co.,Ltd's latest quarterly long term debt in 2024 Q2 was 16 Billion KRW , down 0.0% from previous quarter.
  • Dongwha Pharm.Co.,Ltd reported annual long term debt of 2.04 Billion KRW in 2022, down -59.56% from previous year.
  • Dongwha Pharm.Co.,Ltd reported annual long term debt of 5.05 Billion KRW in 2021, up 24.08% from previous year.
  • Dongwha Pharm.Co.,Ltd reported quarterly long term debt of 16 Billion KRW for 2024 Q1, down -0.79% from previous quarter.
  • Dongwha Pharm.Co.,Ltd reported quarterly long term debt of 2.3 Billion KRW for 2023 Q3, down -9.98% from previous quarter.

Annual Long Term Debt Chart of Dongwha Pharm.Co.,Ltd (2023 - 2006)

Historical Annual Long Term Debt of Dongwha Pharm.Co.,Ltd (2023 - 2006)

Year Long Term Debt Long Term Debt Growth
2023 16.12 Billion KRW 688.9%
2022 2.04 Billion KRW -59.56%
2021 5.05 Billion KRW 24.08%
2020 4.07 Billion KRW -20.36%
2019 5.11 Billion KRW 0.0%
2018 - KRW 0.0%
2017 - KRW 0.0%
2016 - KRW 0.0%
2015 - KRW 0.0%
2014 - KRW -100.0%
2013 2 Billion KRW 0.0%
2012 - KRW -100.0%
2011 10 Billion KRW -45.95%
2010 18.5 Billion KRW 0.0%
2009 - KRW -100.0%
2008 20 Billion KRW 5839.12%
2007 336.75 Million KRW -71.01%
2006 1.16 Billion KRW 0.0%

Peer Long Term Debt Comparison of Dongwha Pharm.Co.,Ltd

Name Long Term Debt Long Term Debt Difference
Yuyu Pharma, Inc. 13.64 Billion KRW -18.238%
Dong-A Socio Holdings Co., Ltd. 202.06 Billion KRW 92.018%
Ildong Holdings Co., Ltd. 29.87 Billion KRW 46.019%
HANDOK Inc. 123.78 Billion KRW 86.971%
Kukje Pharma Co., Ltd. 475.74 Million KRW -3290.0%
Yuhan Corporation 60.23 Billion KRW 73.225%
Dong-A ST Co., Ltd. 161.99 Billion KRW 90.044%
SAMSUNG PHARM. Co., LTD. 101.81 Million KRW -15739.747%
Hanmi Pharm. Co., Ltd. 82.02 Billion KRW 80.339%
Hanall Biopharma Co.,Ltd 590.3 Million KRW -2632.073%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW -166.573%
Dong Sung Bio Pharm.Co.,Ltd. 18.52 Billion KRW 12.929%
MYUNGMOON Pharm co.,Ltd 12.58 Billion KRW -28.158%
Hana Pharm Co., Ltd. 1.59 Billion KRW -908.708%
Yuyu Pharma, Inc. 13.64 Billion KRW -18.238%
Ilsung Pharmaceuticals Co., Ltd. 119.67 Million KRW -13375.849%
REYON Pharmaceutical Co., Ltd. 121 Billion KRW 86.671%
Aprogen pharmaceuticals,Inc. 32 Billion KRW 49.601%
JW Holdings Corporation 20.65 Billion KRW 21.928%
Ildong Pharmaceutical Co., Ltd. 14.82 Billion KRW -8.786%
Chong Kun Dang Pharmaceutical Corp. 30 Billion KRW 46.241%
JW Pharmaceutical Corporation 30 Billion KRW 46.241%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -7265.549%
Hyundai Pharmaceutical Co., Ltd. 580.64 Million KRW -2677.54%
Samil Pharmaceutical Co.,Ltd 49.56 Billion KRW 67.464%
Jeil Pharmaceutical Co.,Ltd 4.45 Billion KRW -262.257%
Yuyu Pharma, Inc. 13.64 Billion KRW -18.238%
Kwang Dong Pharmaceutical Co., Ltd. 19.02 Billion KRW 15.241%
Daewoong pharmaceutical Co.,Ltd 93.41 Billion KRW 82.736%
JW Pharmaceutical Corporation 30 Billion KRW 46.241%
Yuhan Corporation 60.23 Billion KRW 73.225%
Jeil Pharma Holdings Inc 10.5 Billion KRW -53.597%
Yungjin Pharm. Co., Ltd. 40.37 Billion KRW 60.058%
Suheung Co., Ltd. 74 Billion KRW 78.208%
JW Pharmaceutical Corporation 30 Billion KRW 46.241%
Samjin Pharmaceuticals Co., Ltd. 4.16 Billion KRW -287.067%
Korea United Pharm Inc. 10.96 Billion KRW -47.117%
CKD Bio Corp. 69.43 Billion KRW 76.772%
Daewon Pharmaceutical Co., Ltd. 34.57 Billion KRW 53.354%
Whan In Pharm Co.,Ltd. 307.05 Million KRW -5152.354%
Shin Poong Pharm.Co.,Ltd. 218.96 Million KRW -7265.549%
Chong Kun Dang Holdings Corp. 72.11 Billion KRW 77.635%
Boryung Corporation 151.7 Billion KRW 89.369%
Bukwang Pharmaceutical Co., Ltd. 78.52 Billion KRW 79.462%
Ilyang Pharmaceutical Co.,Ltd 6.05 Billion KRW -166.573%
JW Lifescience Corporation 168 Million KRW -9499.81%